Felicia F. Norwood - 23 Apr 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
23 Apr 2024
Net transactions value
-$9,041,318
Form type
4
Filing time
25 Apr 2024, 17:05:29 UTC
Previous filing
19 Mar 2024
Next filing
02 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Options Exercise $1,304,052 +5,473 +14% $238.27 45,571 23 Apr 2024 Direct
transaction ELV Common Stock Sale $7,478,091 -14,011 -31% $533.73 31,560 23 Apr 2024 Direct F1
transaction ELV Common Stock Sale $53,474 -100 -0.32% $534.74 31,460 23 Apr 2024 Direct
transaction ELV Common Stock Options Exercise $486,786 +2,043 +6.5% $238.27 33,503 24 Apr 2024 Direct
transaction ELV Common Stock Sale $1,471,367 -2,765 -8.3% $532.14 30,738 24 Apr 2024 Direct F2
transaction ELV Common Stock Sale $1,829,223 -3,434 -11% $532.68 27,304 24 Apr 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (right to buy) Options Exercise $0 -5,473 -73% $0.000000 2,043 23 Apr 2024 Common Stock 5,473 $238.27 Direct F4
transaction ELV Employee Stock Option (right to buy) Options Exercise $0 -2,043 -100% $0.000000* 0 24 Apr 2024 Common Stock 2,043 $238.27 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $533.60 to $534.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $531.44 to $532.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $532.44 to $533.30. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Fully vested.